entertainment -WSS

entertainment

author：fashion 2025-09-27 07:51:36 - browse：5

Physician groups backed by Welsh, Carson, Anderson & Stowe are looking to influence federal merger policy. Adobe

Three large and growing physician groups backed by the private equity giant Welsh, Carson, Anderson & Stowe have hired a prominent lobbying firm to influence federal policy covering mergers and acquisitions.

Over the past two weeks, United Musculoskeletal Partners, U.S. Anesthesia Partners, and U.S. Radiology Specialists each registered with Forbes Tate Partners, a lobbying shop founded by political insiders who used to work in President Bill Clinton’s administration.

The doctor groups hired Forbes Tate to lobby on “issues related to health care consolidation,” according to federal lobbying disclosures. Each company and Welsh Carson did not respond to inquiries. Forbes Tate also did not respond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： ASCO eve: Let’s set the table for this year's meeting

knowledge

WSS

PBMs are inflating the cost of generic drugs. They must be reined in

Study finds gene variants tied to breast cancer risk in Black women

National associations that represent hospice owe an apology

Investigation reveals sickle cell patients pressured into sterilizations

Eyeing GLP

Study: Spinal cord stimulation helps patients with paralysis walk again

Wikipedia

entertainment

explore

Tori Bowie and the unacceptable rates of Black maternal death

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Study finds gene variants tied to breast cancer risk in Black women

Guidelines to prevent youth baseball injuries need more muscle

How the first Native Hawaiian psychiatrist helped diversify medicine

Alkermes shareholders re

H5N1 bird flu outbreak: Second human case reported, in Michigan

After affirmative action ruling, medical educators look to 'holistic review'

At flashy new research hub, AstraZeneca lays out ambitious growth goals

leisure time

How the drug

Questions and answers about ramping up H5N1 bird flu vaccine

Listen: Vivek Ramaswamy's star turn & leaky drug data

PBMs are inflating the cost of generic drugs. They must be reined in

Eyeing GLP

Scrutiny of post

knowledge

focus

focus

Wikipedia